249 related articles for article (PubMed ID: 2479838)
1. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Bodmer H; Ogg G; Gotch F; McMichael A
Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
[TBL] [Abstract][Full Text] [Related]
2. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH; Lacy E; Ridge JP
J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
[TBL] [Abstract][Full Text] [Related]
3. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
[TBL] [Abstract][Full Text] [Related]
4. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
Takahashi T; Irie RF; Nishinaka Y; Hoon DS
Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
[TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
[TBL] [Abstract][Full Text] [Related]
7. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P
Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389
[TBL] [Abstract][Full Text] [Related]
10. Specificity of peptide binding by the HLA-A2.1 molecule.
Shimojo N; Maloy WL; Anderson RW; Biddison WE; Coligan JE
J Immunol; 1989 Nov; 143(9):2939-47. PubMed ID: 2553813
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
[TBL] [Abstract][Full Text] [Related]
12. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
[TBL] [Abstract][Full Text] [Related]
14. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2.
Bednarek MA; Sauma SY; Gammon MC; Porter G; Tamhankar S; Williamson AR; Zweerink HJ
J Immunol; 1991 Dec; 147(12):4047-53. PubMed ID: 1721637
[TBL] [Abstract][Full Text] [Related]
15. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ
J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876
[TBL] [Abstract][Full Text] [Related]
16. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
17. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
Martinon F; Gomard E; Hannoun C; Lévy JP
Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
[TBL] [Abstract][Full Text] [Related]
18. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
Murray RJ; Brooks JM; Rickinson AB; Rowe M
Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661
[TBL] [Abstract][Full Text] [Related]
19. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a naturally occurring HLA class I-restricted viral epitope.
Falk K; Rötzschke O; Stevanović S; Gnau V; Sparbier K; Jung G; Rammensee HG; Walden P
Immunology; 1994 Jul; 82(3):337-42. PubMed ID: 7525458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
